Crinetics Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Crinetics Pharmaceuticals's estimated annual revenue is currently $2.4M per year.
- Crinetics Pharmaceuticals received $63.5M in venture funding in March 2018.
- Crinetics Pharmaceuticals's estimated revenue per employee is $4,827
- Crinetics Pharmaceuticals's total funding is $446M.
- Crinetics Pharmaceuticals's current valuation is $1.1B. (January 2022)
Employee Data
- Crinetics Pharmaceuticals has 503 Employees.
- Crinetics Pharmaceuticals grew their employee count by 43% last year.
Crinetics Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff to the CEO | Reveal Email/Phone |
2 | Founder, CEO | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | Sr. Director, Medical Affairs Operations & Chief Staff | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Scientific Officer | Reveal Email/Phone |
7 | VP, Investor Relations and Communications | Reveal Email/Phone |
8 | VP, Biology | Reveal Email/Phone |
9 | SVP, Sales & Marketing | Reveal Email/Phone |
10 | VP, Metabolic Diseases | Reveal Email/Phone |
Crinetics Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Crinetics Pharmaceuticals?
Neuropeptide Receptor Targeted Therapeutics for the Treatment of Endocrine Diseases and Cancers. We are driven by a passion for drug-hunting and tempered by a post-recession startup culture. Our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
$446M
Total Funding
503
Number of Employees
$2.4M
Revenue (est)
43%
Employee Growth %
$1.1B
Valuation
N/A
Accelerator
Crinetics Pharmaceuticals News
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Forecasted to ... Defense World
Crinetics Pharmaceuticals Announces Pricing of Underwritten ... GlobeNewswire
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year ... GlobeNewswire
Photo Courtesy of Crinetics San Diego-based Crinetics Pharmaceuticals focuses on discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Radionetics Oncology, a pharmaceutical company developing radiotherapeutics, launched with $30 m ...
SAN DIEGO - October 25, 2021 - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that is has closed it ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $62.9M | 503 | 4% | N/A |
#2 | $91.2M | 503 | N/A | N/A |
#3 | $7.5M | 503 | 2% | N/A |
#4 | $70.4M | 503 | 33% | N/A |
#5 | $200.8M | 504 | 7% | N/A |
Crinetics Pharmaceuticals Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-11-03 | $40.0M | A | 5AM Ventures | Article |
| 2018-03-15 | $63.5M | B | Perceptive Advisors | Article |